Research Frontiers Reports Second Quarter 2020 Financial Results

In this article:

Management to Host Conference Call at 4:30 p.m.

WOODBURY, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its second quarter ended June 30, 2020. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments.

  • Who: Joseph M. Harary, President & CEO, Seth Van Voorhees, CFO

  • Date/Time: August 6, 2020, 4:30 PM ET

  • Dial-in Information: 1-888-334-5785

  • Replay: Available on Friday, August 7, 2020 for 90 days at www.SmartGlass-IR.com

Key Second Quarter 2020 Comments:

1.

In August 2020, Daimay, the world’s largest supplier of automotive sun visors, licensed Research Frontiers’ SPD-Smart light-control film technology for use in automotive sun visors. SPD-Smart light-control technology will enable Daimay to develop products that automatically and dynamically adjust the sun visor to deal with changing light and glare conditions.


2.

In June 2020, Research Frontiers announced that it has been added to the Russell 2000® Index effective on June 29, 2020. The Annual Russell index reconstitution captures the 4,000 largest US stocks ranking them by total market capitalization. Membership in the U.S. Russell 2000 Index® remains in place for one year and also means automatic inclusion in the appropriate growth and value style indices. Russell indices are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.


3.

As discussed on our last investor conference call, in April 2020, Gauzy Ltd. announced that it secured Series C investments from Hyundai Motor Company, Blue Red Partners VC, and Avery Dennison. This strategic investment marks the first known equity investment by an automotive OEM in Research Frontiers’ entire industry.


4.

The Company’s fee income from licensing activities for the six months ended June 30, 2020 was $532,286 as compared to $719,692 for the six months ended June 30, 2019.

  • Lower fees in the automotive and aircraft markets (believed to be related to temporary customer shutdowns in these industries due to the COVID-19 pandemic) was partially offset by higher fee income from licensees in the architectural and display markets.

5.

Total expenses decreased by $452,011, or 20%, for the for the six months ended June 30, 2020 as compared to the same period in 2019.


6.

The Company applied for and received $202,052 in proceeds from the Paycheck Protection Program (“PPP Loan”) made available under the CARES Act. The PPP Loan is intended to offer businesses hurt by the COVID-19 pandemic economic assistance with the potential for the principal to be forgiven based on certain expenses incurred during the first 24 weeks after the issuance of the PPP Loan.

  • The Company estimates that $194,140 of the PPP Loan principal will be forgiven based on payroll and other expenses incurred through June 30, 2020, and all or substantially all of the remaining loan will be forgiven under the terms of the CARES Act during the third quarter of 2020.

7.

As of June 30, 2020, the Company had cash and cash equivalents of $5,841,346 and working capital of $6,270,142.

  • Based upon the Company’s projected cash flow shortfall of approximately $450,000-500,000 per quarter, the Company expects to have sufficient working capital for at least the next 34 months of operations.

For more details, please see the Company’s Quarterly Report on Form 10-Q which was filed today with the SEC, the contents of which are incorporated by reference herein.

About Research Frontiers

Research Frontiers (Nasdaq: REFR) is a publicly traded technology company and the developer of patented SPD-Smart light-control film technology which allows users to instantly, precisely and uniformly control the shading of glass or plastic products, either manually or automatically. Research Frontiers has licensed its smart glass technology to over 40 companies that include well known chemical, material science and glass companies. Products using Research Frontiers’ smart glass technology are being used in tens of thousands of cars, aircraft, yachts, trains, homes, offices, museums and other buildings. For more information, please visit our website at www.SmartGlass.com, and on Facebook, Twitter, LinkedIn and YouTube.

Note: From time to time Research Frontiers may issue forward-looking statements which involve risks and uncertainties. This press release contains forward-looking statements. Actual results, especially those reliant on activities by third parties, could differ and are not guaranteed. Any forward-looking statements should be considered accordingly. “SPD-Smart” and “SPD-SmartGlass” are trademarks of Research Frontiers Inc.

CONTACT:
Seth L. Van Voorhees
Chief Financial Officer
Research Frontiers Inc.
+1-516-364-1902
Info@SmartGlass.com

RESEARCH FRONTIERS INCORPORATED
Consolidated Balance Sheets
Unaudited

June 30, 2020

(Unaudited)

December 31, 2019

Assets

Current assets:

Cash and cash equivalents

$

5,841,346

$

6,591,960

Royalties receivable, net of reserves of $944,052 as of
June 30, 2020 and $1,135,598 as of December 31, 2019

652,520

656,062

Prepaid expenses and other current assets

138,473

58,835

Total current assets

6,632,339

7,306,857

Fixed assets, net

50,942

141,720

Operating lease ROU assets

693,395

773,989

Deposits and other assets

33,567

33,567

Total assets

$

7,410,243

$

8,256,133

Liabilities and Shareholders’ Equity

Current liabilities:

Current portion of operating lease liabilities

$

163,204

$

163,236

Accounts payable

59,438

169,750

Accrued expenses and other

83,342

46,709

Deferred other income liability

7,912

-

Deferred revenue

48,301

7,734

Total current liabilities

362,197

387,429

Operating lease liabilities, net of current portion

731,306

812,596

Total liabilities

1,093,503

1,200,025

Shareholders’ equity:

Common stock, par value $0.0001 per share; authorized 100,000,000 shares, issued and outstanding 31,575,786 in 2020 and 31,254,262 in 2019

3,158

3,125

Additional paid-in capital

122,837,069

122,552,895

Accumulated deficit

(116,523,487

)

(115,499,912

)

Total shareholders’ equity

6,316,740

7,056,108

Total liabilities and shareholders’ equity

$

7,410,243

$

8,256,133


RESEARCH FRONTIERS INCORPORATED
Consolidated Statements of Operations
Unaudited

Six Months Ended June 30,

Three Months Ended June 30,

2020

2019

2020

2019

Fee income

$

532,286

$

719,692

$

176,113

$

301,035

Operating expenses

1,452,404

1,690,520

631,963

939,355

Research and development

330,049

543,944

146,731

313,981

Total expenses

1,782,453

2,234,464

778,694

1,253,336

Operating loss

(1,250,167

)

(1,514,772

)

(602,581

)

(952,301

)

Warrant market adjustment

-

(652,025

)

-

(404,435

)

Other income – PPP loan forgiveness

194,140

-

194,140

-

Net investment income

32,452

12,422

9,460

6,258

Net loss

$

(1,023,575

)

$

(2,154,375

)

$

(398,981

)

$

(1,350,478

)

Basic and diluted net loss per common share

$

(0.03

)

$

(0.07

)

$

(0.01

)

$

(0.05

)

Basic and diluted weighted average number of common shares outstanding

31,398,818

28,909,306

31,474,431

29,589,084


RESEARCH FRONTIERS INCORPORATED
Consolidated Statements of Cash Flows
Unaudited

Six Months Ended June 30,

2020

2019

Cash flows from operating activities:

Net loss

$

(1,023,575

)

$

(2,154,375

)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

87,276

95,445

Stock-based compensation

-

356,228

Other income – PPP loan forgiveness

(194,140

)

-

Bad debts expense

53,217

22,667

Warrant market adjustment

-

652,025

Change in assets and liabilities:

Royalty receivables

(49,675

)

(105,780

)

Prepaid expenses and other current assets

(79,638

)

(49,743

)

Accounts payable and accrued expenses

(73,679

)

(115,475

)

Deferred revenue

40,567

(14,668

)

Net cash used in operating activities

(1,239,647

)

(1,313,676

)

Cash flows from investing activities:

Purchases of fixed assets

(939

)

(62,968

)

Proceeds from the sale of fixed assets

3,713

-

Net cash provided by (used in) investing activities

2,774

(62,968

)

Cash flows from financing activities:

Net proceeds from issuances of common stock and
warrants and exercise of options and warrants

284,207

5,705,898

Proceeds from PPP Program Funding

202,052

-

Net cash provided by financing activities

486,259

5,705,898

Net (decrease) / increase in cash and cash equivalents

(750,614

)

4,329,254

Cash and cash equivalents at beginning of period

6,591,960

2,969,416

Cash and cash equivalents at end of period

$

5,841,346

$

7,298,670


Advertisement